Suppr超能文献

使用胰岛素样生长因子I联合胰岛素样生长因子结合蛋白5、表皮生长因子和玻连蛋白制备用于移植的培养皮肤。

Preparation of cultured skin for transplantation using insulin-like growth factor I in conjunction with insulin-like growth factor binding protein 5, epidermal growth factor, and vitronectin.

作者信息

Dawson Rebecca A, Upton Zee, Malda Jos, Harkin Damien G

机构信息

Tissue Repair and Regeneration Domain, Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Australia.

出版信息

Transplantation. 2006 Jun 27;81(12):1668-76. doi: 10.1097/01.tp.0000226060.51572.89.

Abstract

BACKGROUND

Cultured skin for transplantation is routinely prepared by growing patient keratinocytes in the presence of semidefined sources of growth factors including serum and feeder cells, but these materials require substantial risk remediation and can contribute to transplant rejection.

METHODS

We have therefore investigated the potential of a novel combination of recombinant and purified growth factors to replace serum and feeder cells in cultures of human keratinocytes suitable for clinical application. Our technique was investigated with respect to culture establishment, serial propagation, colony-forming efficiency, immunocytochemistry, epidermal reconstruction, and suitability to support transplantation by aerosolization.

RESULTS

We demonstrate that insulin-like growth factor (IGF)-I--used in conjunction with epidermal growth factor (EGF), insulin-like growth factor binding protein (IGFBP)-5 and vitronectin--supports growth in the absence of serum. Moreover, a threefold greater number of cells are generated within 7 days compared to those grown under current best practice conditions using serum (P<0.05). The resulting test cultures are suitable for epidermal reconstruction and support the option for delivery in the form of an aerosolized cell suspension. Serial propagation, with the view to producing confluent sheets for extensive injuries, was achieved but with less consistency and this result correlated with a significant decline in colony-forming efficiency compared to controls.

CONCLUSIONS

IGF-I used in conjunction with IGFBP-5, EGF, and vitronectin provides a superior alternative to serum for the rapid expansion and transplantation of cultured keratinocytes within the first week of treatment. Nevertheless, further optimization is required with respect to elimination of feeder cells and serial expansion of cultures for treatment of extensive injuries.

摘要

背景

用于移植的培养皮肤通常是通过在包括血清和饲养细胞在内的半确定生长因子来源存在的情况下培养患者角质形成细胞来制备的,但这些材料需要大量风险修复,并且可能导致移植排斥。

方法

因此,我们研究了重组和纯化生长因子的新型组合在适合临床应用的人角质形成细胞培养中替代血清和饲养细胞的潜力。我们从培养建立、连续传代、集落形成效率、免疫细胞化学、表皮重建以及通过雾化支持移植的适用性等方面对我们的技术进行了研究。

结果

我们证明,胰岛素样生长因子(IGF)-I与表皮生长因子(EGF)、胰岛素样生长因子结合蛋白(IGFBP)-5和玻连蛋白联合使用时,可在无血清条件下支持生长。此外,与使用血清的当前最佳实践条件下培养的细胞相比,在7天内产生的细胞数量多出三倍(P<0.05)。所得测试培养物适用于表皮重建,并支持以雾化细胞悬液的形式进行递送。实现了连续传代,以期为大面积损伤生产汇合片,但一致性较差,与对照组相比,集落形成效率显著下降,这一结果与之相关。

结论

IGF-I与IGFBP-5、EGF和玻连蛋白联合使用,为培养角质形成细胞在治疗第一周内的快速扩增和移植提供了优于血清的替代方案。然而,在消除饲养细胞和为大面积损伤的治疗进行培养物的连续扩增方面,仍需要进一步优化。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验